Published in Med Parazitol (Mosk) on March 26, 2004
Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells. J Clin Virol (2009) 1.24
Segment NS of influenza A virus contains an additional gene NSP in positive-sense orientation. Dokl Biochem Biophys (2007) 0.91
[Human dirofilariasis in the Moscow region]. Med Parazitol (Mosk) (2003) 0.87
[Detection of the circulation of Crimean-Congo hemorrhagic fever virus in the piedmont steppes of the North Caucasus]. Vopr Virusol (2005) 0.87
[Clonorchiasis in the People's Republic of Vietnam. 2. The clinico-parasitological examination of a focus and a trial of prazinquantel treatment]. Med Parazitol (Mosk) (1992) 0.83
Specific biochemical features of replication of clinical influenza viruses in human intestinal cell culture. Biochemistry (Mosc) (2007) 0.80
[Clinical importance of hemolysis in the prophylactic treatment of malaria using primaquine on persons with a glucose-6-phosphate dehydrogenase deficit]. Med Parazitol (Mosk) (1975) 0.79
[Dirofilariasis in the Moscow Region, a low disease transmission risk area]. Med Parazitol (Mosk) (2011) 0.79
[A possible association of fatal pneumonia with mutations of pandemic influenza A/H1N1 sw1 virus in the receptor-binding site of the HA1 subunit]. Vopr Virusol (2010) 0.79
[Heterogeneity of hepatitis B virus and diagnostic potential of modern test systems for the detection of HBsAg]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.77
[Results of studies of human dirofilariasis in Russia]. Med Parazitol (Mosk) (2014) 0.77
[Impact of changes in the amino acid sequence of the "a" determinant on the diagnostic capacities of test systems for the detection of HBsAg]. Vopr Virusol (2011) 0.77
[Propagation of hepatitis E virus in an endemic and nonendemic regions]. Vopr Virusol (2002) 0.77
[Pathogenic effect of pandemic influenza virus H1N1 under replication in cultures of human cells]. Vopr Virusol (2013) 0.77
[HCV genome variability in acute and chronic viral hepatitis C]. Ter Arkh (2009) 0.77
[Efficacy of ingavirin in adults with influenza]. Ter Arkh (2009) 0.77
[Clinico-parasitological research in a mixed focus of clonorchiasis and intestinal nematodiasis in Hanamnin Province (the Socialist Republic of Vietnam)]. Med Parazitol (Mosk) (1990) 0.76
[Opisthorchiasis and alcoholism: a clinico-epidemiological and social psychology study]. Med Parazitol (Mosk) (1990) 0.76
[Clinical effectiveness of aprotinin aerosol in influenza and parainfluenza]. Vestn Ross Akad Med Nauk (1996) 0.76
[The procedure for the wide use of praziquantel in a complex of measures to control opisthorchiasis. 1. The tolerance and efficacy of different doses of biltricide during outpatient use in foci]. Med Parazitol (Mosk) (1995) 0.76
[Epidemiological pattern of scarlet fever in recent years]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.75
[Emergence of tick-borne spotted fever group rickettsiosis in Moscow]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.75
[Spread of new pandemic influenza A(H1N1)v virus in Russia]. Vopr Virusol (2010) 0.75
[Radionuclide and sonographic diagnosis of lesions of the hepatobiliary system in opisthorchiasis]. Med Parazitol (Mosk) (1990) 0.75
[A fatal case of trichinelliasis with intensive invasion and acute massive hemorrhage from a stomach ulcer]. Med Parazitol (Mosk) (1998) 0.75
[Evolution of epidemiology]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.75
[The initial experience with embovin treatment in a a focus of intestinal nematode infections in the Socialist Republic of Vietnam]. Med Parazitol (Mosk) (1994) 0.75
[Cytomegalovirus infection in women of reproductive age with an at-risk obstetrical history]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.75
[Acute fatty gestational hepatosis in infectious and obstetrical clinic]. Klin Med (Mosk) (2002) 0.75
[Listeriosis: variants of a clinical course]. Ter Arkh (2001) 0.75
[An analysis of opisthorchiasis and diphyllobothriasis morbidity of the local and native populations in endemic foci by 3 exponential models with a determination of the epidemic potential]. Med Parazitol (Mosk) (1988) 0.75
[Invasive streptococcal (group A) infection: an outlook (review)]. Ter Arkh (2004) 0.75
[The pathogenetic therapy of acute respiratory diseases by aprotinin inhalations]. Ter Arkh (1995) 0.75
[Listeriosis with affection of the nervous system]. Ter Arkh (2007) 0.75
[An analysis of the results of clinical trials of praziquantel analogs in intestinal cestode and trematode infections. 2. The treatment of liver trematode infections (opisthorchiasis, fascioliasis) and schistosomiasis]. Med Parazitol (Mosk) (1994) 0.75
[A new method for ureterocystoneostomy]. Urol Nefrol (Mosk) (1997) 0.75
[The real place of infectious pathology in overall population morbidity]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75
[Initial experience in the use of praziquantel on an outpatient basis in a focus of opisthorchiasis in the Ukrainian SSR]. Med Parazitol (Mosk) (1988) 0.75
[Perinatal transmission of hepatitis C virus]. Vopr Virusol (2009) 0.75
[The antidiphtheria activity of the pre-EGF fragment]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75
[Classification of human diseases and prophylaxis of morbidity among the population]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.75
[Man and parasites: an example of combined evolution]. Vestn Ross Akad Med Nauk (2000) 0.75
[Evaluation of the immunogenic and reactogenic properties of vaccine "Euvax B" in persons aged 16-18 years in different geographical zones of Russia]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75
[The isolation of patients with highly contagious diseases]. Vestn Ross Akad Med Nauk (2004) 0.75
[Search for and perspectives of new methods of treatment of severe forms of hepatitis B]. Ter Arkh (1980) 0.75
[The clinico-epidemiological characteristics of opisthorchiasis foci in the Yamalo-Nenets Autonomous Okrug and the treatment results with praziquantel]. Med Parazitol (Mosk) (1992) 0.75
[The procedure for the wide use of praziquantel in a complex of measures to control opisthorchiasis. 2. The tolerance and efficacy of Russian-made azinox in mass treatment in foci]. Med Parazitol (Mosk) (1995) 0.75
[Intestinal trematodiases (metagonimiasis, nanophyetiasis): clinico-parasitological research and the first trial of using Azinox in a focus of the lower Amur River valley]. Med Parazitol (Mosk) (1992) 0.75
[The first trial of azinox treatment in a clonorchiasis focus in the Socialist Republic of Vietnam]. Med Parazitol (Mosk) (1993) 0.75
[Pseudoinvasion and transient carriage of the larvae of arthropods and soil nematodes in humans: problems and consequences. The authors' observations and a literature review]. Med Parazitol (Mosk) (2014) 0.75
[Effect of hepatitis G virus on the course of acute hepatitis B and C]. Vopr Virusol (2000) 0.75
[Clinical course and outcome of acute hepatitis B in relation to the markers of the E system]. Ross Med Zh (1992) 0.75
[Outcomes of severe pandemic influenza A/H1N1/2009]. Ter Arkh (2010) 0.75
[Criteria for the severity of viral hepatitis]. Ter Arkh (1979) 0.75
[Kallikrein and prekallikrein content and antitryptic activity in the blood serum in serum hepatitis of varying degrees of severity]. Vopr Med Khim (1982) 0.75
[Present-day Clinical characteristics of scarlatina]. Ter Arkh (2004) 0.75
[Actual problems in diagnosis and treatment of imported malaria]. Med Parazitol (Mosk) (2001) 0.75
[Prospects for interferon therapy in chronic hepatitis C with normal transaminase levels]. Ter Arkh (2002) 0.75
[Clinico-immunological characteristics of Cytomegalovirus infection in pregnant women in different methods of treatment (report II)]. Akush Ginekol (Mosk) (1990) 0.75
[Use of personal protective equipment by pathologists and legal physicians working with particularly dangerous infectious diseases]. Arkh Patol (1991) 0.75
[Opisthorchiasis in the Moscow and Vladimir regions]. Med Parazitol (Mosk) (1989) 0.75
[Advanced intestinal myiasis]. Klin Med (Mosk) (2004) 0.75
[Antidiphtheria activity of epidermal growth factor precursor fragment]. Biull Eksp Biol Med (1999) 0.75
[Prasiquantel treatment of patients under ambulatory conditions in an opisthorchiasis focus in the Komi-Permyak autonomous area]. Med Parazitol (Mosk) (1989) 0.75
[Diagnosis of Cytomegalovirus infection in pregnancy (report I)]. Akush Ginekol (Mosk) (1990) 0.75
[A case of severe granlocytopoiesis depression in a female patient with albendazole-treated cystic hydatid disease of the liver]. Med Parazitol (Mosk) (2008) 0.75
[Epidemiology is a developing system of views]. Med Parazitol (Mosk) (2003) 0.75
[Hepatitis C virus proteins in the liver cells in acute hepatitis C: their association with liver damage and with the outcome of the disease]. Vopr Virusol (2005) 0.75
[Analysis of the causes of opisthorchiasis treatment failure in a focus of invasion]. Med Parazitol (Mosk) (1987) 0.75
[A comparative evaluation of detection of antibodies to hepatitis C virus in different immunoassay test system and verification tests]. Vopr Virusol (2004) 0.75
[Evaluation of the efficiency of external assessment of the quality of determining antibodies to hepatitis C virus in the network of screening laboratories]. Vopr Virusol (2008) 0.75
[What surgeon must know about rabies and its treatment]. Khirurgiia (Mosk) (2004) 0.75
[An analysis of the results of clinical trials of praziquantel analogs in intestinal cestode and trematode infections. 1. The treatment of intestinal cestode infections (diphyllobothriasis, taeniasis, hymenolepiasis)]. Med Parazitol (Mosk) (1994) 0.75
[A first trial of the use of normaze in the combined treatment of opisthorchiasis patients under outpatient conditions in an endemic focus]. Med Parazitol (Mosk) (1995) 0.75
[Pandemic influenza in Russia: specific features of clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease]. Ter Arkh (2011) 0.75
[Prospects of use coryneformic bacteria drug to prevent and treat respiratory infections]. Vestn Ross Akad Med Nauk (2008) 0.75
[Clinical assessment of immunoglobulin E in the blood and the level of circulating immune complexes in parasitic diseases. 3. Opisthorchiasis]. Med Parazitol (Mosk) (1990) 0.75
[Evaluation of the system for controlling the quality of the HBsAg detection in the system of screening laboratories]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.75
[Cases of trichinellesis in citizens of Moscow]. Ter Arkh (2006) 0.75
[Etiotropic therapy of influenza: lessons from the last pandemic]. Vestn Ross Akad Med Nauk (2011) 0.75
[Diagnosis of opisthorchiasis using the membrane filtration technique]. Lab Delo (1990) 0.75
[Differences in the dynamics of the eosinophilia, blood immunoglobulin E and the level of circulating immune complexes in patients with chronic opisthorchiasis treated with different doses of praziquantel]. Med Parazitol (Mosk) (1993) 0.75
[The status of and outlook for improving the diagnosis of acute intestinal infections at the prehospital stage]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[Invasive streptococcal (group A) infection: an overview]. Ter Arkh (2005) 0.75
[The morphological changes in the small intestine of cats with metagonimiasis]. Med Parazitol (Mosk) (1992) 0.75
[Efficacy of ozeltamivir (Tamiflu) in adult influenza on the epidemic rise of morbidity in Russia in the 2006-2007 season]. Vopr Virusol (2008) 0.75
[Comprehensive assessment of an opisthorchiasis focus in the Komi-Permiak Autonomous Okrug]. Med Parazitol (Mosk) (1989) 0.75
[The modern analysis and prediction of the spread of acute respiratory viral infections]. Zh Mikrobiol Epidemiol Immunobiol (1996) 0.75
[Clinical and laboratory evaluation of efficiency and tolerance of the "Nikavir" in acute hepatitis B]. Vopr Virusol (2003) 0.75
[Use of new individual protection substances in Mel'tser boxes]. Vestn Ross Akad Med Nauk (2004) 0.75
[Migrating subcutaneous myasis with systemic manifestations caused by gadfly larvae]. Klin Med (Mosk) (2004) 0.75
[An analysis of 4 strategies for the praziquantel treatment of persons infested with Opisthorchis felineus under conditions excluding reinfestation]. Med Parazitol (Mosk) (1989) 0.75
[The immune status in variants of the course and outcome of acute delta virus infection]. Ter Arkh (1988) 0.75
[The clinico-parasitological examination of a focus of intestinal nematodiases in Ha-Shon-Bin Province in the People's Republic of Vietnam and an analysis of 5 medamine treatment schemes]. Med Parazitol (Mosk) (1992) 0.75
[Experience in treating severe viral respiratory infection caused by influenza A (H1N1)]. Anesteziol Reanimatol (2010) 0.75
[Calculating the magnitude of the economic damage caused by diseases]. Med Parazitol (Mosk) (2005) 0.75